1. Home
  2. ATOS vs QMMM Comparison

ATOS vs QMMM Comparison

Compare ATOS & QMMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATOS
  • QMMM
  • Stock Information
  • Founded
  • ATOS 2009
  • QMMM 2005
  • Country
  • ATOS United States
  • QMMM Hong Kong
  • Employees
  • ATOS N/A
  • QMMM N/A
  • Industry
  • ATOS Biotechnology: Pharmaceutical Preparations
  • QMMM
  • Sector
  • ATOS Health Care
  • QMMM
  • Exchange
  • ATOS Nasdaq
  • QMMM NYSE
  • Market Cap
  • ATOS 174.8M
  • QMMM 196.2M
  • IPO Year
  • ATOS 2012
  • QMMM 2024
  • Fundamental
  • Price
  • ATOS $1.19
  • QMMM $0.58
  • Analyst Decision
  • ATOS Strong Buy
  • QMMM
  • Analyst Count
  • ATOS 3
  • QMMM 0
  • Target Price
  • ATOS $6.75
  • QMMM N/A
  • AVG Volume (30 Days)
  • ATOS 738.2K
  • QMMM 2.1M
  • Earning Date
  • ATOS 11-12-2024
  • QMMM 12-03-2024
  • Dividend Yield
  • ATOS N/A
  • QMMM N/A
  • EPS Growth
  • ATOS N/A
  • QMMM N/A
  • EPS
  • ATOS N/A
  • QMMM N/A
  • Revenue
  • ATOS N/A
  • QMMM $3,510,653.00
  • Revenue This Year
  • ATOS N/A
  • QMMM N/A
  • Revenue Next Year
  • ATOS N/A
  • QMMM N/A
  • P/E Ratio
  • ATOS N/A
  • QMMM N/A
  • Revenue Growth
  • ATOS N/A
  • QMMM 20.09
  • 52 Week Low
  • ATOS $0.70
  • QMMM $0.54
  • 52 Week High
  • ATOS $2.31
  • QMMM $13.00
  • Technical
  • Relative Strength Index (RSI)
  • ATOS 31.91
  • QMMM N/A
  • Support Level
  • ATOS $1.26
  • QMMM N/A
  • Resistance Level
  • ATOS $1.66
  • QMMM N/A
  • Average True Range (ATR)
  • ATOS 0.09
  • QMMM 0.00
  • MACD
  • ATOS -0.03
  • QMMM 0.00
  • Stochastic Oscillator
  • ATOS 4.08
  • QMMM 0.00

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

About QMMM QMMM HOLDINGS LIMITED

QMMM Holdings Ltd is a digital advertising and marketing production services company. It operates through its two wholly-owned subsidiaries. It has used interactive design, animation, art-tech and virtual technologies in over 500 commercial campaigns. The company has worked with large domestic and international banks, real estate developers, amusement parks, top international athletic apparel and footwear brands, and luxury cosmetic products and international brands for their advertising and creation work in Hong Kong. Its clients include local and international banks, real-estate developers, luxury brands, high fashion houses, and theme parks.

Share on Social Networks: